AMIA’s goal is to improve the legislative and regulatory environment for health informatics research, practice and education through AMIA member expertise. The primary pathway through which AMIA achieves this goal is by engaging Federal Agencies and Congress on public calls for input, such as Notices of Proposed Rulemakings (NPRMs) or Request for Information (RFIs).
Learn more about the comment process
AMIA responses are arranged by Federal Agency and Congressional Committee.
Farzad Mostashari, MD
Office of the National Coordinator
Hubert H. Humphrey Building,
Suite 729D, 200 Independence Ave. SW.
Washington, DC 20201
Re: Health Information Technology: Standards, Implementation Specifications, and Certification Criteria for Electronic Health Record Technology, 2014 Edition; Revisions to the Permanent Certification Program for Health Information Technology
Dear Dr […]
AMIA and the NIWG submitted comments in response to the Patient-Centered Outcomes Research Institute’s (PCORI’s) request for comments about its draft National Priorities for Research and Research Agenda. PCORI was created to fund research that will give patients, caregivers, and clinicians more information to support health care decisions. AMIA thanked […]
Along with several other organizations, AMIA is participating in the Coalition for an Informed Patient Identity Integrity Solution. The Coalition is working to delete prohibiting language from the fiscal year 2012 Labor, HHS Appropriations bill, and to substitute language that would have HHS conduct a study of the health information […]
AMIA acknowledged NIST’s efforts to highlight the importance of usability testing for electronic health records (EHRs) through its issuance of the proposed guidance. AMIA expressed concerns about several aspects of the draft guidance including the following: a limited and narrow identification of EHR users; the need to consider more comprehensive […]
AMIA and its Nursing Informatics Working Group once again provided input to the National Quality Forum (NQF) during an open comment period to solicit input on NQF's Quality Data Model (QDM). In its comments, AMIA recognized the importance of having an information model that clearly defines concepts used in quality […]
This week AMIA submitted comments to the Department of Health and Human Services (HHS) in response to the a request for comments regarding Human Subject Research Protections: Enhancing Protections for Research Subjects and Reducing Burden, Delay, and Ambiguity for Investigators (aka "the Common Rule").
Click below to read AMIA's comments.
AMIA recently issued comments in response to a U.S. Food and Drug Administration (FDA) draft guidance on mobile medical applications. In the comments, AMIA president Ted Shortliffe noted, among other things, the need for additional clarification, definitions, terms, and terminology in the guidance. Click below to read AMIA's full comments.
In response to the U.S. Food and Drug Administration (FDA) invitation AMIA participated in a public workshop on the FDA’s Draft Guidance on mobile medical applications. AMIA, the association for informatics professionals, made a presentation and participated in panel discussions that advised the FDA on how it should approach its […]
AMIA has commented on a recent HHS notice of proposed rulemaking (NPRM) to modify the Health Insurance Portability and Accountability Act of 1996 (HIPAA) Privacy Rule's standard for accounting of disclosures of protected health information. The purpose of the modifications spelled out in the NPRM is, in part, to implement […]
AMIA President and CEO Ted Shortliffe sent a letter today to ONC director Farzad Mostashari and the leadership of all Regional Extension Centers (RECs) regarding a recent AMIA Board position paper on vendor agreements. Click below for a PDF copy of the letter.